Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The primary objective of this study is to evaluate the efficacy of 2 fixed dosages of Prolonged Release (PR) OROS methylphenidate (54 and 72 mg/day) compared with placebo in adult subjects with attention deficit/hyperactivity disorder (ADHD).
Critère d'inclusion
- Attention-Deficit/Hyperactivity Disorder (ADHD)